These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 33006916)

  • 21. Pharmacogenetic testing in pediatric neurology: a pragmatic study evaluating clinician and patient perceptions.
    Pépin MA; Otis AS; Tremblay Z; Boulé M; Lebel D; Major P; Lortie A; Pinchefsky E; Rossignol E; Carleton B; Bussières JF; Métras MÉ
    Per Med; 2022 Sep; 19(5):423-434. PubMed ID: 35830229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preemptive Panel-Based Pharmacogenetic Testing: The Time is Now.
    Weitzel KW; Cavallari LH; Lesko LJ
    Pharm Res; 2017 Aug; 34(8):1551-1555. PubMed ID: 28466392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Personalizing medicine with clinical pharmacogenetics.
    Scott SA
    Genet Med; 2011 Dec; 13(12):987-95. PubMed ID: 22095251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Personalised pharmacogenetics. Evidence-based guidelines and clinical application of pharmacogenetic diagnostics].
    Stingl JC; Brockmöller J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1509-21. PubMed ID: 24170080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenetics in Child and Adolescent Psychiatry: Background and Evidence-Based Clinical Applications.
    Malik S; Verma P; Ruaño G; Al Siaghy A; Dilawar A; Bishop JR; Strawn JR; Namerow LB
    J Child Adolesc Psychopharmacol; 2024 Feb; 34(1):4-20. PubMed ID: 38377525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies and settings of clinical pharmacogenetic implementation: a scoping review of pharmacogenetics programs.
    Luczak T; Brown SJ; Armbruster D; Hundertmark M; Brown J; Stenehjem D
    Pharmacogenomics; 2021 Apr; 22(6):345-364. PubMed ID: 33829852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of clinical pharmacogenetic recommendations across therapeutic areas.
    Shugg T; Pasternak AL; Luzum JA
    Pharmacogenet Genomics; 2022 Feb; 32(2):51-59. PubMed ID: 34412102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PARC report: a perspective on the state of clinical pharmacogenomics testing.
    Eichmeyer J; Rogers S; Formea CM; Giri J; Jones JS; Schnettler E; Schmidlen T; Glogowski E; Kurz RN
    Pharmacogenomics; 2020 Jul; 21(11):809-820. PubMed ID: 32635876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and regulatory considerations in pharmacogenetic testing.
    Schuck RN; Marek E; Rogers H; Pacanowski M
    Am J Health Syst Pharm; 2016 Dec; 73(23):1999-2006. PubMed ID: 27864207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Translating genotype data of 44,000 biobank participants into clinical pharmacogenetic recommendations: challenges and solutions.
    Reisberg S; Krebs K; Lepamets M; Kals M; Mägi R; Metsalu K; Lauschke VM; Vilo J; Milani L
    Genet Med; 2019 Jun; 21(6):1345-1354. PubMed ID: 30327539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical education in pharmacogenomics-results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx).
    Just KS; Steffens M; Swen JJ; Patrinos GP; Guchelaar HJ; Stingl JC
    Eur J Clin Pharmacol; 2017 Oct; 73(10):1247-1252. PubMed ID: 28669097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preliminary outcomes of preemptive warfarin pharmacogenetic testing at a large rural healthcare center.
    Leary E; Brilliant M; Peissig P; Griesbach S
    Am J Health Syst Pharm; 2019 Feb; 76(6):387-397. PubMed ID: 31415684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical pharmacogenetics: how do we ensure a favorable future for patients?
    Wiltshire T; Dong OM
    Pharmacogenomics; 2018 Apr; 19(6):553-562. PubMed ID: 29620450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Personalized drug therapy based on genetics. Possibilities and examples from clinical practice].
    Stingl JC; Just KS; Kaumanns K; Schurig-Urbaniak M; Scholl C; von Mallek D; Brockmöller J
    Internist (Berl); 2016 Mar; 57(3):289-97. PubMed ID: 26830424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrating Pharmacogenetic Decision Support into a Clinical Information System.
    Tippenhauer K; Philips M; Largiadèr CR; Sariyar M; Bürkle T
    Stud Health Technol Inform; 2020 Jun; 270():618-622. PubMed ID: 32570457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterizing Pharmacogenetic Testing Among Children's Hospitals.
    Brown JT; Ramsey LB; Van Driest SL; Aka I; Colace SI
    Clin Transl Sci; 2021 Mar; 14(2):692-701. PubMed ID: 33325650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
    Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
    Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of Pharmacogenetic Information in Food and Drug Administration Drug Labeling and the Table of Pharmacogenetic Associations.
    Cheng CM; So TW; Bubp JL
    Ann Pharmacother; 2021 Oct; 55(10):1185-1194. PubMed ID: 33384014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands.
    Bank PCD; Swen JJ; Guchelaar HJ
    BMC Med; 2019 Jun; 17(1):110. PubMed ID: 31196067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetic testing in oncology: a Brazilian perspective.
    Suarez-Kurtz G
    Clinics (Sao Paulo); 2018 Oct; 73(suppl 1):e565s. PubMed ID: 30328952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.